Sfrp4-flox Mouse
一般名
Sfrp4-flox
製品ID
S-CKO-05011
背景情報
C57BL/6NCya
系統ID
CKOCMP-20379-Sfrp4-B6N-VA
状況
このマウス系統を論文で使用する場合は、「Sfrp4-flox Mouse(カタログ番号S-CKO-05011)はサイアジェンから購入しました。」と引用してください。
製品タイプ
年齢
遺伝子型
性別
数量
標準的な配送方法では、少なくとも3匹のヘテロ接合体キャリアを保証しています。ホモ接合体キャリアや指定された性別の個体の繁殖サービスも利用可能です。
基本情報
系統名
Sfrp4-flox
系統ID
CKOCMP-20379-Sfrp4-B6N-VA
遺伝子名
製品ID
S-CKO-05011
遺伝子別名
--
遺伝子別名
C57BL/6NCya
NCBI ID
修正
Conditional knockout
染色体
Chr 13
表現型
アプリケーション
--
さらに
系統詳細
EnsemblトランスクリプトID
ENSMUST00000002883
NCBIトランスクリプトID
NM_016687
ターゲット領域
Exon 4
有効領域の大きさ
~1.8 kb
遺伝子研究の概要
Sfrp4, Secreted Frizzled Receptor Protein 4, is a decoy receptor for Wnt ligands, playing a crucial role in various biological processes. It is involved in the regulation of Wnt signaling pathways, which are essential for normal development, cell differentiation, and tissue homeostasis. Sfrp4 has significance in multiple biological systems, including the skeletal, reproductive, and cardiovascular systems, and its study using genetic models, like KO mouse models, has provided valuable insights into its functions [1-10].
In the skeletal system, Sfrp4 loss-of-function mutations cause Pyle disease, characterized by cortical bone thinning and increased fragility fractures despite increased trabecular bone density. On the endosteal surface, it represses non-canonical Wnt signaling to regulate endosteal resorption. In the periosteum, Sfrp4 is crucial for the expansion and differentiation of periosteal stem cell/progenitor cells. Sfrp4 deletion decreases the pool of Ctsk-lineage periosteal stem cells, impairs their multipotency, and hampers the periosteal response to bone injury [1,2].
In the ovary, Sfrp4-null female mice are hyperfertile due to decreased antral follicle atresia and enhanced ovulation rates. Sfrp4 promotes autophagy and blunts FSH responsiveness in ovarian granulosa cells through inhibition of AKT signaling. It also contributes to insulin-resistance-induced polycystic ovary syndrome by triggering ovarian granulosa cell hyperandrogenism and apoptosis through the nuclear β-catenin/IL-6 signaling axis [3,6,7].
In ApoE-deficient mice, overexpression of SFRP4 reduces atherosclerosis plaque formation [4]. In gastric cancer, elevated SFRP4 expression is linked to a poor prognosis and is associated with immune cell infiltration [5]. In endometrial carcinoma, PBX1 promotes SFRP4 transcription, which inhibits cell proliferation and epithelial-mesenchymal transition [8].
In conclusion, Sfrp4 is a key regulator in multiple biological processes. Studies using KO mouse models have revealed its important roles in bone development, female fertility, and disease conditions such as Pyle disease, polycystic ovary syndrome, atherosclerosis, and certain cancers. Understanding Sfrp4 functions provides potential therapeutic targets for these diseases.
References:
1. Chen, Ruiying, Baron, Roland, Gori, Francesca. 2022. Sfrp4 and the Biology of Cortical Bone. In Current osteoporosis reports, 20, 153-161. doi:10.1007/s11914-022-00727-w. https://pubmed.ncbi.nlm.nih.gov/35182301/
2. Chen, Ruiying, Dong, Han, Raval, Dhairya, Greenblatt, Matthew B, Gori, Francesca. 2023. Sfrp4 is required to maintain Ctsk-lineage periosteal stem cell niche function. In Proceedings of the National Academy of Sciences of the United States of America, 120, e2312677120. doi:10.1073/pnas.2312677120. https://pubmed.ncbi.nlm.nih.gov/37931101/
3. Bérubé, Michael, Abedini, Atefeh, Lapointe, Evelyne, Zamberlam, Gustavo, Boerboom, Derek. 2024. SFRP4 promotes autophagy and blunts FSH responsiveness through inhibition of AKT signaling in ovarian granulosa cells. In Cell communication and signaling : CCS, 22, 396. doi:10.1186/s12964-024-01736-1. https://pubmed.ncbi.nlm.nih.gov/39138534/
4. Guan, Hua, Liu, Ting, Liu, Miaomiao, Shi, Tao, Guo, Fengwei. 2023. SFRP4 Reduces Atherosclerosis Plaque Formation in ApoE Deficient Mice. In Cardiology research and practice, 2023, 8302289. doi:10.1155/2023/8302289. https://pubmed.ncbi.nlm.nih.gov/37143778/
5. Yu, Pengcheng, He, Weiyang, Zhang, Yanqiang, Cheng, Xiangdong, Xu, Zhiyuan. 2022. SFRP4 Is a Potential Biomarker for the Prognosis and Immunotherapy for Gastric Cancer. In Journal of oncology, 2022, 8829649. doi:10.1155/2022/8829649. https://pubmed.ncbi.nlm.nih.gov/35847366/
6. Zamberlam, Gustavo, Lapointe, Evelyne, Abedini, Atefeh, DeMayo, Francesco J, Boerboom, Derek. . SFRP4 Is a Negative Regulator of Ovarian Follicle Development and Female Fertility. In Endocrinology, 160, 1561-1572. doi:10.1210/en.2019-00212. https://pubmed.ncbi.nlm.nih.gov/30942852/
7. Wang, Jiangxia, Gui, Runlin, Li, Yang, Fan, Xiaobin, Xiong, Yuyan. 2024. SFRP4 contributes to insulin resistance-induced polycystic ovary syndrome by triggering ovarian granulosa cell hyperandrogenism and apoptosis through the nuclear β-catenin/IL-6 signaling axis. In Biochimica et biophysica acta. Molecular cell research, 1871, 119822. doi:10.1016/j.bbamcr.2024.119822. https://pubmed.ncbi.nlm.nih.gov/39159685/
8. Guo, Liwen, Chen, Huihua, Chen, Jinguo, Chen, Zichun, Cao, Luoyuan. 2023. PBX1-promoted SFRP4 transcription inhibits cell proliferation and epithelial-mesenchymal transition in endometrial carcinoma. In Tissue & cell, 82, 102083. doi:10.1016/j.tice.2023.102083. https://pubmed.ncbi.nlm.nih.gov/37054536/
品質管理基準
精子検査
凍結前の精子濃度を測定し、精子の生存能力の判定します。
凍結後の精子では、各バッチから1本の凍結保存された精子を選び出し、体外受精に使用します。
環境基準:
SPF対応地域:
グローバル由来:
Cyagenお問い合わせ
カスタムの動物モデルに関するご相談は、下記のフォームにご記入いただき、ご連絡いただくか見積もりをご依頼ください。
Cyagenはお客様のプライバシーを大変重視しています。当社の最新の製品や情報をお届けしたいと思っています。お客様の設定をご確認ください。
これらの配信はいつでも解除できます。配信停止方法およびデータ保護の詳細は プライバシーポリシー をご確認ください。
以下のボタンをクリックすることで、このフォームにご入力いただいた個人情報をCyagenが保存・処理し、ご要望のコンテンツを提供することに同意されたことになります。
